[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Checkpoint Inhibitors for Treating Cancer Market Analysis 2015-2019 and Forecast 2020-2025

January 2020 | 101 pages | ID: GF1EE9FFE12EN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Checkpoint Inhibitors for Treating Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • PD-1 inhibitors
  • PD-L1 inhibitors
  • CTLA-4 inhibitors
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Bristol-Myers Squibb(BMS)
  • Merck
  • Roche
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Melanoma treatment
  • Bladder cancer treatment
  • Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Checkpoint Inhibitors for Treating Cancer Industry
Figure Checkpoint Inhibitors for Treating Cancer Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Checkpoint Inhibitors for Treating Cancer
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer
  1.2.2 Downstream
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET BY TYPE

3.1 By Type
  3.1.1 PD-1 inhibitors
Table Major Company List of PD-1 inhibitors
  3.1.2 PD-L1 inhibitors
Table Major Company List of PD-L1 inhibitors
  3.1.3 CTLA-4 inhibitors
Table Major Company List of CTLA-4 inhibitors
3.2 Market Size
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2019, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Type, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
  4.1.1 Bristol-Myers Squibb(BMS) Profile
Table Bristol-Myers Squibb(BMS) Overview List
  4.1.2 Bristol-Myers Squibb(BMS) Products & Services
  4.1.3 Bristol-Myers Squibb(BMS) Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
  4.2.1 Merck Profile
Table Merck Overview List
  4.2.2 Merck Products & Services
  4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Roche (Company Profile, Sales Data etc.)
  4.3.1 Roche Profile
Table Roche Overview List
  4.3.2 Roche Products & Services
  4.3.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2015-2019, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share in 2019, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2015-2019, by Company, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2019
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2019
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2019
Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2019
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2019

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Melanoma treatment
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2015-2019, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2015-2019, in Volume
  6.1.2 Demand in Bladder cancer treatment
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2015-2019, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2015-2019, in Volume
  6.1.3 Demand in Others
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2015-2019, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2020-2025, by Application, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Market Growth 2020-2025, by Application, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Market Share in 2025, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2020-2025, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Growth 2020-2025, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Share in 2025, by Application, in Volume

7 REGION OPERATION

7.1 Regional Production
Table Checkpoint Inhibitors for Treating Cancer Production 2015-2019, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2015-2019, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2015-2019, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2025, by Application, in USD Million
Table Major Company List of PD-L1 inhibitors
Table Major Company List of CTLA-4 inhibitors
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2015-2019, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2015-2019, by Company, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2020-2025, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2020-2025, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Growth 2020-2025, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Share in 2025, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Production 2015-2019, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Production 2015-2019, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2015-2019, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2019, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2015-2019, by Region, in Volume
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2015-2019, by Country, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

LIST OF FIGURES

Figure Checkpoint Inhibitors for Treating Cancer Industry Chain Structure
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2019, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2019, by Type, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share in 2019, by Company, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share in 2019, by Company, in Volume
Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2019
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2019
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2019
Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2019
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2019
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2015-2019, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2015-2019, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2015-2019, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2015-2019, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2015-2019, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2015-2019, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Market Growth 2020-2025, by Application, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Market Share in 2025, by Application, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2019, in Volume
Figure Marketing Channels Overview


More Publications